CJM Wealth Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$996K Buy
3,922
+41
+1% +$9.55K 0.26% 37
2026
Q1
$949K Buy
3,881
+12
+0.3% +$2.79K 0.29% 34
2025
Q4
$801K Sell
3,869
-714
-16% -$141K 0.24% 34
2025
Q3
$850K Buy
4,583
+1,501
+49% +$257K 0.26% 33
2025
Q2
$471K Buy
3,082
+1
+0% +$154 0.16% 44
2025
Q1
$511K Sell
3,081
-95
-3% -$14.9K 0.18% 40
2024
Q4
$459K Hold
3,176
0.15% 42
2024
Q3
$515K Buy
3,176
+101
+3% +$16.1K 0.18% 38
2024
Q2
$450K Sell
3,075
-722
-19% -$107K 0.17% 38
2024
Q1
$601K Buy
3,797
+294
+8% +$46.8K 0.23% 34
2023
Q4
$549K Sell
3,503
-48
-1% -$7.36K 0.24% 35
2023
Q3
$553K Sell
3,551
-86
-2% -$14.2K 0.27% 34
2023
Q2
$602K Buy
3,637
+2
+0.1% +$323 0.31% 30
2023
Q1
$563K Buy
3,635
+2
+0.1% +$323 0.32% 30
2022
Q4
$642K Buy
3,633
+1
+0% +$173 0.39% 27
2022
Q3
$593K Buy
3,632
+160
+5% +$27.1K 0.42% 27
2022
Q2
$616K Buy
3,472
+63
+2% +$11.2K 0.43% 27
2022
Q1
$604K Hold
3,409
0.41% 28
2021
Q4
$583K Buy
+3,409
New +$558K 0.41% 32

Other funds holding JNJ

CJM Wealth Advisers's JNJ Position: Q2 2026 in Review

CJM Wealth Advisers increased its Johnson & Johnson (JNJ) stake by 1.1% in Q2 2026, buying an estimated $9.55K and bringing the position to 3,922 shares worth $996K. The position accounts for 0.26% of the portfolio, ranked #37.

CJM Wealth Advisers first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 1,173 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • CJM Wealth Advisers held 3,922 shares of Johnson & Johnson worth $996K as of Q2 2026.
  • CJM Wealth Advisers bought 41 Johnson & Johnson shares in Q2 2026, an estimated $9.55K.
  • Johnson & Johnson made up 0.26% of CJM Wealth Advisers's portfolio in Q2 2026, its #37 holding.
  • CJM Wealth Advisers first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 1,173 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on CJM Wealth Advisers's 13F filing for Q2 2026, filed 17 Jul 2026.